Ticagrelor Versus Clopidogrel in Patients with Late or Very Late Stent Thrombosis.
Jinying ZhouYu TanChen LiuPeng ZhouZhaoxue ShengJiannan LiRunzhen ChenHanjun ZhaoLi SongHong-Bing YanPublished in: Cardiovascular drugs and therapy (2020)
Following successful primary PCI, patients with LST/VLST who received ticagrelor had fewer ischemic cardiovascular events at 1-yr follow-up, compared with those who received clopidogrel.
Keyphrases
- cardiovascular events
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery bypass grafting
- cardiovascular disease
- pulmonary embolism
- coronary artery bypass
- type diabetes
- heart failure
- atrial fibrillation
- oxidative stress
- brain injury